Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Evans, M. Bulman, K. Young, D. Gokhale, F. Lalloo (2004)
High detection rate for BRCA2 mutations in male breast cancer families from North West EnglandFamilial Cancer, 1
I. Roisman, Z. Gimon, V. Barak (1989)
[Male breast cancer].Harefuah, 117 3-4
J. Eden (2010)
Breast cancer, stem cells and sex hormones: part 1. The impact of fetal life and infancy.Maturitas, 67 2
R. Schwartz, R. Newell, James Hauch, William Fairweather (1980)
A study of familial male breast carcinoma and a second reportCancer, 46
J. Demeter, N. Waterman, G. Verdi (1990)
Familial male breast carcinomaCancer, 65
IS Fentiman, A Fourquet, GN Hortobagyi (2006)
Male breast cancerLancet, 367
A. Chalon, Z. Teo, D. Park, F. Odefrey, J. Hopper, M. Southey, kConFab (2010)
Are PALB2 mutations associated with increased risk of male breast cancer?Breast Cancer Research and Treatment, 121
D. Evans, M. Bulman, K. Young, E. Howard, S. Bayliss, A. Wallace, F. Lalloo (2007)
BRCA1/2 mutation analysis in male breast cancer families from North West EnglandFamilial Cancer, 7
F. Couch, Linda Farid, M. Deshano, S. Tavtigian, K. Calzone, Lisa Campeau, Yi Peng, Bert Bogden, Qian Chen, S. Neuhausen, D. Shattuck-Eidens, A. Godwin, M. Daly, D. Radford, S. Sedlacek, J. Rommens, J. Simard, J. Garber, S. Merajver, B. Weber (1996)
BRCA2 germline mutations in male breast cancer cases and breast cancer familiesNature Genetics, 13
Corinne Jones, D. Oliver, A. Merwyk (1996)
Familial male breast cancerMedical Journal of Australia, 164
A. Cassoni (1969)
TNM: CLASSIFICATION OF MALIGNANT TUMOURSMedical Journal of Australia, 1
AR Hauser, IJ Lerner, RA King (1992)
Familial male breast cancerAm J Med Genet, 44
K. Syrjäkoski, T. Kuukasjärvi, A. Auvinen, O. Kallioniemi (2004)
CHEK2 1100delC is not a risk factor for male breast cancer populationInternational Journal of Cancer, 108
S. Onami, M. Ozaki, J. Mortimer, S. Pal (2010)
Male breast cancer: an update in diagnosis, treatment and molecular profiling.Maturitas, 65 4
C. Wittekind, M. Gospodarowicz, L. Sobin (2009)
Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley
A. Dejgård, P. Petersen, J. Kastrup (1988)
MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHYThe Lancet, 331
S. Lanitis, A. Rice, A. Vaughan, P. Cathcart, G. Filippakis, R. Mufti, D. Hadjiminas (2008)
Diagnosis and Management of Male Breast CancerWorld Journal of Surgery, 32
L. Korde, J. Zujewski, L. Kamin, S. Giordano, S. Domchek, W. Anderson, J. Bartlett, K. Gelmon, Z. Nahleh, J. Bergh, B. Cutuli, G. Pruneri, W. McCaskill-Stevens, J. Gralow, G. Hortobagyi, F. Cardoso (2010)
Multidisciplinary meeting on male breast cancer: summary and research recommendations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 12
G. Parmigiani, D. Berry, O. Aguilar (1998)
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.American journal of human genetics, 62 1
E. Ruder, J. Dorgan, S. Kranz, P. Kris-Etherton, T. Hartman (2008)
Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence.Clinical breast cancer, 8 4
R. Everson, J. Fraumeni, RichardE. Wilson, Frederick Li, J. Fishman, David Stout, H. Norris (1976)
FAMILIAL MALE BREAST CANCERThe Lancet, 307
A. Meindl, H. Hellebrand, C. Wiek, Verena Erven, B. Wappenschmidt, D. Niederacher, M. Freund, P. Lichtner, Linda Hartmann, H. Schaal, J. Ramser, E. Honisch, C. Kubisch, H. Wichmann, K. Kast, H. Deissler, C. Engel, B. Müller-Myhsok, K. Neveling, M. Kiechle, C. Mathew, D. Schindler, R. Schmutzler, H. Hanenberg (2010)
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneNature Genetics, 42
I. Zanna, P. Rizzolo, F. Sera, M. Falchetti, P. Aretini, G. Giannini, G. Masala, A. Gulino, D. Palli, L. Ottini (2010)
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer casesEuropean Journal of Human Genetics, 18
N. Mavaddat, A. Antoniou, D. Easton, M. García-Closas (2010)
Genetic susceptibility to breast cancerMolecular Oncology, 4
K. Offit, H. Pierce, T. Kirchhoff, P. Kolachana, B. Rapaport, P. Gregersen, S. Johnson, O. Yossepowitch, Helen Huang, J. Satagopan, M. Robson, Lauren Scheuer, K. Nafa, N. Ellis (2003)
Frequency of CHEK2*1100delC in New York breast cancer cases and controlsBMC Medical Genetics, 4
N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, Anna Elliott, S. Reid, Katarina Spanova, R. Barfoot, T. Chagtai, H. Jayatilake, L. McGuffog, S. Hanks, D. Evans, D. Eccles, D. Easton, Michael Stratton (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 39
G. Miolo, L. Puppa, M. Santarosa, C. Giacomi, A. Veronesi, E. Bidoli, M. Tibiletti, A. Viel, R. Dolcetti (2006)
Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of ItalyBMC Cancer, 6
S. Giordano (2005)
A review of the diagnosis and management of male breast cancer.The oncologist, 10 7
S. Neuhausen, A. Dunning, L. Steele, Kazuko Yakumo, Michael Hoffman, C. Szabo, L. Tee, C. Baines, P. Pharoah, D. Goldgar, D. Easton (2004)
Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancersInternational Journal of Cancer, 108
N. Sodha, C. Wilson, S. Bullock, H. Phillimore, R. Houlston, R. Eeles (2004)
Analysis of familial male breast cancer for germline mutations in CHEK2.Cancer letters, 215 2
T. Ohayon, I. Gal, R. Baruch, C. Szabo, E. Friedman (2004)
CHEK2*1100delC and male breast cancer risk in IsraelInternational Journal of Cancer, 108
M. Amin, S. Edge, F. Greene, D. Byrd, R. Brookland, M. Washington, J. Gershenwald, C. Compton, K. Hess, D. Sullivan, J. Jessup, J. Brierley, L. Gaspar, R. Schilsky, C. Balch, D. Winchester, E. Asare, M. Madera, Donna Gress, L. Meyer (2002)
AJCC Cancer Staging Manual
I. Tournier, B. Paillerets, H. Sobol, D. Stoppa-Lyonnet, R. Lidereau, M. Barrois, S. Mazoyer, F. Coulet, A. Hardouin, A. Chompret, A. Lortholary, P. Chappuis, V. Bourdon, V. Bonadona, C. Maugard, Brigitte Gilbert, C. Noguès, T. Frebourg, M. Tosi (2004)
Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer FamiliesCancer Research, 64
(2009)
UICC: TNM classification of malignant tumors
The term “familial male breast cancer” is often misleading, because in the breast cancer families reported in the literature, the vast majority of the patients were women and only a few were men. In this report, we present the rare case of a strictly defined familial male breast cancer (MBC) in which exclusively men were diagnosed with breast cancer. Three of four brothers developed the disease between the age of 46 and 64 years within a period of 21 years whereas all female relatives remained unaffected. The three affected men did not show the typical known clinical and genetic risk factors for MBC. An X-linked recessive inheritance may be possible in these cases. One way to potentially improve the identification of the causes of MBC could be a through a strictly studying families in which the male members were exclusively diagnosed with this malignancy. This approach emphasizes familial MBC as a distinct entity and not only as a variant of female breast cancer.
Familial Cancer – Springer Journals
Published: Nov 9, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.